Sarepta Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Sarepta Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Sarepta Therapeutics Inc
Rating: 1.82950
Author: Trendlyne DVM scores

Expensive Underperformer

about

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targ...

18.60 -0.35 (-1.85%)

86.60% Fall from 52W High

2.9M

XNAS Volume

XNAS 04 Sep, 2025 2:15 PM (EDT)

Medium Financial Strength

50.0 / 100

Expensive Valuation

26.0 / 100

Technically Bearish

20.4 / 100

Expensive Underperformer These stocks are medium in financial scores. They have bad valuation and technical scores as well. View Similar Embed DVM

1Yr Price target upside is 28%

25 analysts

Sarepta Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Sarepta Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targ...

86.60% Fall from 52W High

SWOT Analysis

Sarepta Therapeutics Inc Live Price Chart